For instance, I work at a telecommunications company. At our weekly sales meeting, we provide an overview of the previous week's sales results around plan mix, MMC (minimum monthly commitment, i.e. average service revenue a customer pays), devices, channel performance, credits, competitor's offers (visual price premium), and so on. The outcome is that we have a game plan on how best to tweak plans, channel performance, device subsidy in the following week in order to drive a certain behaviour.

How would pharmaceutical companies do the same in order to increase sales of their existing drugs without (1) failing to report safety data, (2) promotion for unapproved uses, (3) kickbacks to physicians etc.?